Healthcare (SH:603313) Zhong Guo Zheng Quan Bao·2026-01-30 12:46Core Viewpoint - The company Mengbaihe (603313) has announced a positive earnings forecast for 2025, projecting a net profit attributable to shareholders between 90 million to 130 million yuan, a significant recovery from a loss of 151 million yuan in the previous year [4] Financial Performance - The expected net profit for 2025 represents a turnaround from the previous year's loss, with a projected non-recurring net profit of 50 million to 70 million yuan, compared to a loss of 280 million yuan last year [4] - Historical financial data shows a trend of recovery, with the company moving from significant losses in prior years to expected profitability in 2025 [5] Valuation Metrics - As of January 30, the company's price-to-earnings (P/E) ratio is estimated to be between 43.8 and 63.27 times, with a price-to-book (P/B) ratio of approximately 1.54 times and a price-to-sales (P/S) ratio of about 0.63 times [4] - The P/E and P/S ratios are calculated using trailing twelve months (TTM) data, while the P/B ratio is based on the latest financial report [9] Business Operations - Mengbaihe focuses on the research, development, production, and sales of home products aimed at enhancing deep sleep, including memory foam mattresses, pillows, sofas, electric beds, and other home goods [4] - The company attributes its improved performance to a reduction in asset impairment losses and strengthened market expansion efforts, particularly in domestic and international markets, along with enhanced brand development and online business growth [4]